Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
RATIONALE: Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction and vascular remodeling. Recent studies have revealed that immune and inflammatory responses play a crucial role in pathogenesis of idiopathic PAH. OBJECTIVES: To systematically evaluate the number and cross-sectional distribution of inflammatory cells in different sizes of pulmonary arteries from explanted lungs of patients with idiopathic PAH versus healthy donor lungs and to demonstrate functional relevance by blocking stromal-derived factor-1 by the Spiegelmer NOX-A12 in monocrotaline-induced pulmonary hypertension in rats. METHODS: Immunohistochemistry was performed on lung tissue sections from patients with idiopathic PAH and healthy donors. All positively stained cells in whole-lung tissue sections, surrounding the vessels, and in the different compartments of the vessels were counted. To study the effects of blocking SDF-1, rats with monocrotaline-induced pulmonary hypertension were treated with NOX-A12 from Day 21 to Day 35 after monocrotaline administration. MEASUREMENTS AND MAIN RESULTS: We found a significant increase of the perivascular number of macrophages (CD68(+)), macrophages/monocytes (CD14(+)), mast cells (toluidine blue(+)), dendritic cells (CD209(+)), T cells (CD3(+)), cytotoxic T cells (CD8(+)), and helper T cells (CD4(+)) in vessels of idiopathic PAH lungs compared with control subjects. FoxP3(+) mononuclear cells were significantly decreased. In the monocrotaline model, the NOX-A12-induced reduction of mast cells, CD68(+) macrophages, and CD3(+) T cells was associated with improvement of hemodynamics and pulmonary vascular remodeling. CONCLUSIONS: Our findings reveal altered perivascular inflammatory cell infiltration in pulmonary vascular lesions of patients with idiopathic pulmonary arterial hypertension. Targeting attraction of inflammatory cells by blocking stromal-derived factor-1 may be a novel approach for treatment of PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555
Tuder, R. M., Groves, B. Μ., Badesch, D. B., & Voelkel, N. F. (1994) · PubMed · Cited by 891
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Hassoun, P. M., Mouthon, L., Barberà, J. A., Eddahibi, S., Flores, S. C., Grimminger, F., Jones, P. L., Maitland, M. L., Michelakis, E. D., Morrell, N. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.006 · Cited by 710
Self-citationModern Age Pathology of Pulmonary Arterial Hypertension
Stacher, E., Graham, B. B., Hunt, J. M., Gandjeva, A., Groshong, S. D., McLaughlin, V. V., Jessup, M., Grizzle, W. E., Aldred, M. A., Cool, C. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0164oc · Cited by 667
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C. L., Söker, S., Niknejad, K., Peoples, G. E., & Klagsbrun, M. (1995) · PubMed · Cited by 438
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
Bonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610467104 · Cited by 364
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Perros, F., Dorfmüller, P., Montani, D., Hammad, H., Waelput, W., Girerd, B., Raymond, N., Mercier, O., Mussot, S., Cohen-Kaminsky, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0927oc · Cited by 308
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
DORFMÜLLER, P., ZARKA, V., DURAND-GASSELIN, I., MONTI, G., BALABANIAN, K., GARCIA, G., CAPRON, F., COULOMB-LHERMINÉ, A., MARFAING-KOKA, A., SIMONNEAU, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus
Liu, M. ‐., Wang, C. ‐., Fung, L. ‐., & Wu, C. ‐. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01370.x · Cited by 282
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 274
Vergadi, E., Chang, M. S., Lee, C., Liang, O. D., Liu, X., Fernandez-Gonzalez, A., Mitsialis, S. A., & Kourembanas, S. (2011) · Circulation · doi:10.1161/circulationaha.110.978627 · Cited by 267
Autoimmunity and pulmonary hypertension: a perspective
Nicolls, M. R., Taraseviciene-Stewart, L., Rai, P. R., Badesch, D. B., & Voelkel, N. F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00045705 · Cited by 261
Pulmonary arterial remodeling induced by a Th2 immune response
Daley, E., Emson, C., Guignabert, C., de Waal Malefyt, R., Louten, J., Kurup, V. P., Hogaboam, C., Taraseviciene-Stewart, L., Voelkel, N. F., Rabinovitch, M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071008 · Cited by 253
Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension
Sanchez, O., Marcos, E., Perros, F., Fadel, E., Tu, L., Humbert, M., Dartevelle, P., Simonneau, G., Adnot, S., & Eddahibi, S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1559oc · Cited by 228
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension
Perros, F., Dorfmüller, P., Souza, R., Durand-Gasselin, I., Mussot, S., Mazmanian, M., Hervé, P., Emilie, D., Simonneau, G., & Humbert, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00094706 · Cited by 194
Burke, D. L., Frid, M. G., Kunrath, C. L., Karoor, V., Anwar, A., Wagner, B. D., Strassheim, D., & Stenmark, K. R. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90591.2008 · Cited by 180
Mach, F., Schönbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J.-Y., Graber, P., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65269-8 · Cited by 175
Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension
Tamby, M. C., Humbert, M. J. C., Guilpain, P., Servettaz, A., Dupin, N., Christner, J. J., Simonneau, G., Fermanian, J., Weill, B. J., Guillevin, L., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00152705 · Cited by 151
Lévy, M., Maurey, C., Celermajer, D. S., Vouhé, P. R., Danel, C. J., Bonnet, D., & Israël‐Biet, D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.049 · Cited by 150
Hypoxia, leukocytes, and the pulmonary circulation
Stenmark, K. R., Davie, N. J., Reeves, J. Τ., & Frid, M. G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00840.2004 · Cited by 122
Darisipudi, M. N., Kulkarni, O. P., Sayyed, S. G., Ryu, M., Migliorini, A., Sagrinati, C., Parente, E., Vater, A., Eulberg, D., Klußmann, S., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.004 · Cited by 121
Self-citationWu, Q., Salomon, B. L., Chen, M., Wang, Y., Hoffman, L. M., Bluestone, J. A., & Fu, Y. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1327 · Cited by 121
T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension
Austin, E. D., Rock, M. T., Mosse, C. A., Vnencak‐Jones, C. L., Yoder, S. M., Robbins, I. M., Loyd, J. E., & Meyrick, B. O. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.004 · Cited by 100
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Gambaryan, N., Perros, F., Montani, D., Cohen‐Kaminsky, S., Mazmanian, M. G., Renaud, J. F., Simonneau, G., Lombet, A., & Humbert, M. J. C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00045710 · Cited by 98
The Noncanonical WNT Pathway Is Operative in Idiopathic Pulmonary Arterial Hypertension
Laumanns, I. P., Fink, L., Wilhelm, J., Wolff, J.-C., Mitnacht‐Kraus, R., Graef-Hoechst, S., Stein, M. M., Bohle, R. M., Klepetko, W., Hoda, M. A. R., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0153oc · Cited by 94
Self-citationFuture Perspectives for the Treatment of Pulmonary Arterial Hypertension
Ghofrani, H. A., Barst, R. J., Benza, R. L., Champion, H. C., Fagan, K. A., Grimminger, F., Humbert, M. J. C., Simonneau, G., Stewart, D. J., Ventura, C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.014 · Cited by 88
Self-citationLung mast cells in plexogenic pulmonary arteriopathy.
Heath, D., & Yacoub, M. H. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.12.1003 · Cited by 82
Macrophages: Promising Targets for the Treatment of Atherosclerosis
Wilson, H. M., Barker, R. N., & Erwig, L. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787455635 · Cited by 69
Bennaceur, K., Popa, I., Portoukalian, J., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl024 · Cited by 63
Hall, S., Brogan, P. A., Haworth, S. G., & Klein, N. J. (2009) · Thorax · doi:10.1136/thx.2008.106435 · Cited by 50
Yu, L., & Hales, C. A. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-21 · Cited by 50
The Janus Face of CD4+CD25+ Regulatory T Cells in Cancer and Autoimmunity
Danese, S., & Rutella, S. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780059599 · Cited by 34
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Cited by
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Tuder, R. M., Archer, S. L., Dorfmüller, P., Erzurum, S. C., Guignabert, C., Michelakis, E., Rabinovitch, M., Schermuly, R., Stenmark, K. R., & Morrell, N. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.025 · Cited by 585
Self-citationThe Adventitia: Essential Regulator of Vascular Wall Structure and Function
Stenmark, K. R., Yeager, M. E., El Kasmi, K. C., Nozik-Grayck, E., Gerasimovskaya, E. V., Li, M., Riddle, S. R., & Frid, M. G. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183802 · Cited by 464
Pathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Good, R. B., Gilbane, A. J., Trinder, S. L., Denton, C. P., Coghlan, G., Abraham, D. J., & Holmes, A. M. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.03.019 · Cited by 349
“Ahealthy pulmonary endothelial barrier is integral to regulating the extravasation of cells and cytokines from the blood and to maintaining vascular homeostasis.1 Dysfunction of the endothelial barrier can occur in response to inflammatory mediators such as IL-6 and tumor necrosis factor a (TNFa), as well as pathogens…”
BackgroundInfluential
Metadata
- Authors
- Savai, R., Pullamsetti, S. S., Kolbe, J., Bieniek, E., Voswinckel, R., Fink, L., Scheed, A., Ritter, C., Dahal, B. K., Vater, A., Klussmann, S., Ghofrani, H. A., Weissmann, N., Klepetko, W., Banat, G. A., Seeger, W., Grimminger, F., & Schermuly, R. T.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-01
- Volume
- 186
- Issue
- 9
- Pages
- 897-908
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2162698108
- Cited by
- 408
- References
- 37
- FWCI
- 15.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.